NCT00214617View on ClinicalTrials.gov

Effect of Crestor on Lipoprotein Metabolism in Humans

PHASE4CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

January 31, 2005

Study Completion Date

February 28, 2006

Conditions
Hypercholesterolemia
Interventions
DRUG

Rosuvastatin at 5 mg/day and 40 mg/day

Trial Locations (1)

30033

Atlanta Research and Education Foundation, Decatur

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Foundation for Atlanta Veterans Education and Research, Inc.

OTHER

NCT00214617 - Effect of Crestor on Lipoprotein Metabolism in Humans | Biotech Hunter | Biotech Hunter